Ärzte in einem Operationssaal (Symbolbild).
Mittwoch, 22.03.2017 11:00 von | Aufrufe: 44

Parallax Health Sciences, Inc. Receives Favorable Judgment in Legal Case with Previous owner of RoxSan Pharmacy

Ärzte in einem Operationssaal (Symbolbild). © FangXiaNuo / E+ / Getty Images http://www.gettyimages.de/

PR Newswire

SANTA MONICA, Calif., March 22, 2017 /PRNewswire/ -- Parallax Health Sciences, Inc. ("Parallax" or the "Company") (PRLX), the owner of RoxSan Pharmacy, Inc., is pleased to announce that on March 17, 2017, in Melamed v. Parallax Health Sciences, Inc., Los Angeles Superior Court Case No. SC124873, (the "Matter"), a Ruling was issued in favor of Defendant, Parallax Health Sciences, Inc. ("the Company"). In the Matter, Plaintiff, Shahla Melamed, sought rescission of the August 13, 2015, Agreement pursuant to which Parallax acquired 100% of the Issued and Outstanding Shares of RoxSan Pharmacy, Inc. and Its Assets and Inventory (the "Purchase Agreement").  Rescission was sought on the basis that in order to acquire RoxSan Pharmacy, Inc., the Defendant and its principals had allegedly defrauded Plaintiff, there had allegedly been a complete failure of consideration, and there had allegedly been a unilateral mistake by Plaintiff.

The Court ruled that no fraud on the part of Defendant or its principals had been demonstrated.  The Court further ruled that there had been no failure of consideration, and that Plaintiff's entry into the Agreement was not a result of a unilateral mistake on her part.  Therefore, the Court ruled that the Plaintiff is not entitled to rescission of the Purchase Agreement.

"Litigation was never our preferred course of action in our dispute with the former owner. However, we were always confident in the merits of our case and are very pleased with the court's decision," stated J. Michael Redmond, President/CEO of Parallax. "The Company has spent countless hours and significant expense defending the Company in this matter. We are looking forward to being able to focus our efforts on growing the RoxSan business and executing our overall Company strategy for the remainder of 2017."

Parallax was represented by Arthur Lensky, Esq of Lensky Law Firm, Los Angeles, CA and Ronald G. Rosenberg of Rosenberg & Koffman, Los Angeles, CA.

ABOUT PARALLAX HEALTH SCIENCES, INC.

Parallax Health Sciences, Inc. (PRLX), with offices in Santa Monica, CA, is a fully reporting Nevada corporation. Parallax is focused on personalized patient healthcare through its Pharmacy and Infertility business, and through Parallax Health Management and Parallax Diagnostics. Please visit www.parallaxhealthsciences.com.

ABOUT ROXSAN PHARMACY, INC.


ARIVA.DE Börsen-Geflüster

RoxSan Pharmacy, Inc. a wholly owned subsidiary of Parallax Health Sciences, Inc., is a 60 year old Beverly Hills, CA based Pharmacy specializing in compound prescriptions and infertility treatments. RoxSan Pharmacy is licensed in 42 States in the US. Please visit www.roxsan.com

 

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/parallax-health-sciences-inc-receives-favorable-judgment-in-legal-case-with-previous-owner-of-roxsan-pharmacy-300427549.html

SOURCE Parallax Health Sciences, Inc.

Werbung

Mehr Nachrichten zur Parallax Health Sciences Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Andere Nutzer interessierten sich auch für folgende News